HK4597A - Nutritional, pharmaceutical and cosmetic compositions containing di-linoleoyl-mono-gamma-linolenyl-glycerol - Google Patents

Nutritional, pharmaceutical and cosmetic compositions containing di-linoleoyl-mono-gamma-linolenyl-glycerol

Info

Publication number
HK4597A
HK4597A HK4597A HK4597A HK4597A HK 4597 A HK4597 A HK 4597A HK 4597 A HK4597 A HK 4597A HK 4597 A HK4597 A HK 4597A HK 4597 A HK4597 A HK 4597A
Authority
HK
Hong Kong
Prior art keywords
gla
oil
dlmg
oil according
oils
Prior art date
Application number
HK4597A
Other languages
English (en)
French (fr)
Inventor
David F. Horrobin
Huang Yung-Sheng
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of HK4597A publication Critical patent/HK4597A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/52—Esters of acyclic unsaturated carboxylic acids having the esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/587—Monocarboxylic acid esters having at least two carbon-to-carbon double bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fats And Perfumes (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Detergent Compositions (AREA)
  • Edible Oils And Fats (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Amplifiers (AREA)
  • Logic Circuits (AREA)

Claims (9)

  1. Ein natürliches oder synthetisches Glyzeridöl, angereichert durch oder mit dem Zusatz von Dilinoleoyl-Mono-Gamma-Linolenyl-Glyzerol (DLMG), das mindestens 20 Massenanteile vorzugsweise mindestens 25 Massenanteile, noch besser mindestens 40 Massenanteile DLMG, enthält.
  2. Ein Öl nach Anspruch 1, das mindestens 60 Massenanteile, vorzugsweise mindestens 90 Massenanteile, noch besser mindestens 98 Massenanteile Triglyzerid enthält.
  3. Ein Öl nach Anspruch 1 oder 2, das ein nach pharmazeutischen oder Ernährungsgesichtspunkten akzeptables Öl ist.
  4. Verwendung eines Öls nach den Ansprüchen 1 bis 3, oder als Zusatz zu einem Nahrungsmittelzusatz oder als eine oder als Zusatz zu einer Nahrungsergänzung oder als eine oder als Zusatz zu besonderer Nahrung für Kleininder, ältere Kinder oder Erwachsene.
  5. Eine pharmazeutische Zusammensetzung, die ein Öl nach den Ansprüchen 1 bis 3 sowie einen pharmazeutische akzeptablen Träger enthält.
  6. Eine Zusammensetzung für Kosmetik oder Hautpflege, die aus einem Öl nach den Ansprüchen 1 bis 3 besteht, zur Verwendung bei der Behandlung von normaler, geschädigter oder kranker Haut.
  7. Die Verwendung eines Öls nach den Ansprüchen 1 bis 3 in einem Präparat zur Verwendung bei der Pflege oder Behandlung von normalem, geschädigtem oder kranken Haar oder Kopfhaut.
  8. Die Verwendung eines Öls nach den Ansprüchen 1 bis 3 in einem Präparat eines Arzneimittels zur Behandlung von GLS-Mangel.
  9. Die Verwendung eines Öls nach den Ansprüchen 1 bis 3 im Präparat eines Arzneimittels zur Behandlung einer Störung aus den Bereichen endogenes Ekzem, Brustschmerzen oder prämenstruelles Syndrom.
HK4597A 1991-06-03 1997-01-09 Nutritional, pharmaceutical and cosmetic compositions containing di-linoleoyl-mono-gamma-linolenyl-glycerol HK4597A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919111900A GB9111900D0 (en) 1991-06-03 1991-06-03 Fatty acid compositions

Publications (1)

Publication Number Publication Date
HK4597A true HK4597A (en) 1997-01-17

Family

ID=10695999

Family Applications (1)

Application Number Title Priority Date Filing Date
HK4597A HK4597A (en) 1991-06-03 1997-01-09 Nutritional, pharmaceutical and cosmetic compositions containing di-linoleoyl-mono-gamma-linolenyl-glycerol

Country Status (20)

Country Link
US (4) US5328691A (de)
EP (1) EP0520624B1 (de)
JP (1) JP2704922B2 (de)
KR (2) KR100274727B1 (de)
AT (1) ATE136214T1 (de)
AU (1) AU652827B2 (de)
CA (1) CA2069600C (de)
DE (1) DE69209571T2 (de)
DK (1) DK0520624T3 (de)
ES (1) ES2085567T3 (de)
FI (1) FI103867B1 (de)
GB (1) GB9111900D0 (de)
GR (1) GR3019840T3 (de)
HK (1) HK4597A (de)
IE (1) IE75224B1 (de)
NO (1) NO180804C (de)
NZ (1) NZ242898A (de)
SG (1) SG49739A1 (de)
TW (1) TW288975B (de)
ZA (1) ZA923913B (de)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU683027B2 (en) * 1993-01-27 1997-10-30 Scotia Holdings Plc Triglycerides
GB9304746D0 (en) * 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
FR2706304B1 (fr) * 1993-06-15 1995-09-01 Carita Sa Utilisation des huiles de Chaulmoogra dans le domaine cosmétique et pharmaceutique, notamment en dermatologie, pour harmoniser la pigmentation de la peau.
GB9325445D0 (en) 1993-12-13 1994-02-16 Cortecs Ltd Pharmaceutical formulations
GB9403855D0 (en) * 1994-03-01 1994-04-20 Scotia Holdings Plc Fatty acid derivatives
NZ280017A (en) * 1994-09-21 1997-06-24 Scotia Holdings Plc Use of n-6 or n-3 series essential fatty acid (efa), and optionally an oestrogen, to make a medicament to treat or prevent hormone replacement therapy (hrt) associated breast pain in peri- or postmenopausal women; medicaments containing the efa and estrogen.
EP0711503A3 (de) * 1994-11-14 1997-11-26 Scotia Holdings Plc Mit GLA und/oder DGLA angereicherte Milch
US5639460A (en) * 1995-06-07 1997-06-17 Raymond; Hal C. Aqueous plant extract having antiviral activity
US5959131A (en) * 1995-12-07 1999-09-28 Kraft Foods, Inc. Nutritionally superior fat for food compositions
DE69724782T3 (de) * 1996-03-28 2015-12-24 Dsm Ip Assets B.V. Verfahren zur Herstellung von granulärer mikrobieller Biomasse und Gewinnung wertvoller Komponenten aus mikrobieller Biomasse
CN1217029A (zh) * 1996-03-28 1999-05-19 吉斯特-布罗卡迪斯股份有限公司 从用巴氏法灭菌的生物量中制备含有微生物多不饱和脂肪酸的油的方法
US6255505B1 (en) 1996-03-28 2001-07-03 Gist-Brocades, B.V. Microbial polyunsaturated fatty acid containing oil from pasteurised biomass
ATE353689T1 (de) 1997-07-16 2007-03-15 Metacure Nv Einrichtung zur steuerung eines glatten muskels
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
US7138431B1 (en) 1998-02-23 2006-11-21 Wake Forest University Dietary control of arachidonic acid metabolism
US8666495B2 (en) 1999-03-05 2014-03-04 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
GB9918023D0 (en) * 1999-07-30 1999-09-29 Unilever Plc Skin care composition
ES2291333T3 (es) * 2000-06-27 2008-03-01 Qualilife Pharmaceuticals Inc. Composiciones y metodos para el tratamiento de la respuesta sexual de las mujeres.
US6506412B2 (en) * 2000-11-29 2003-01-14 Sciencebased Health Treatment of dry eye syndrome
BRPI0311906B1 (pt) 2002-06-19 2017-02-21 Dsm Ip Assets Bv processo para obtenção de um ácido graxo poliinsaturado (pufa) ou um óleo microbiano de células microbianas
WO2004012753A1 (en) * 2002-07-31 2004-02-12 Helfried Hans Rudolf Crede Pharmaceutical composition containing black cumin oil, flax oil and borago oil
JP4153912B2 (ja) 2002-10-23 2008-09-24 Ａｚエレクトロニックマテリアルズ株式会社 化学増幅ポジ型感光性樹脂組成物
CN1816287A (zh) * 2003-01-31 2006-08-09 宝洁公司 改善哺乳动物角质组织外观的方法
US20050123500A1 (en) * 2003-01-31 2005-06-09 The Procter & Gamble Company Means for improving the appearance of mammalian hair and nails
GB0311081D0 (en) 2003-05-14 2003-06-18 Btg Internat Limted Treatment of neurodegenerative conditions
US8792985B2 (en) 2003-07-21 2014-07-29 Metacure Limited Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar
JP2007502805A (ja) 2003-08-18 2007-02-15 ビーティージー・インターナショナル・リミテッド 神経変性状態の処置
JP2006061021A (ja) * 2004-08-24 2006-03-09 Suntory Ltd １種類の高度不飽和脂肪酸残基３個から成るトリグリセライドの製造方法、およびその利用
US8343753B2 (en) * 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
JP2010042037A (ja) * 2009-11-26 2010-02-25 Suntory Holdings Ltd １種類の高度不飽和脂肪酸残基３個から成るトリグリセライドの製造方法、およびその利用
US8934975B2 (en) 2010-02-01 2015-01-13 Metacure Limited Gastrointestinal electrical therapy
US20120252888A1 (en) * 2011-03-29 2012-10-04 Palupa Medical Ltd. Compositions and Methods for Treating Neurologic Disorders
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
CN105899485B (zh) 2013-11-15 2018-10-19 尊严科学有限公司 多不饱和羟基脂肪酸的药学上可接受的盐
RU2714323C2 (ru) * 2014-06-04 2020-02-14 ДиЭс БАЙОФАРМА ЛИМИТЕД Фармацевтические композиции, содержащие дглк, и их применение
EP3273954B1 (de) 2015-03-26 2020-10-28 Tiberio Bruzzese Gereinigte zusammensetzungen aus mehrfach ungesättigten fettsäuren, deren herstellungsverfahren und deren verwendung
CN113896628A (zh) 2015-05-13 2022-01-07 Ds生物制药有限公司 包含15-氧代-epa或15-氧代-dgla的组合物及其制备和使用方法
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172149A (en) * 1978-01-30 1979-10-23 Westwood Pharmaceuticals, Inc. Method for treating living skin exhibiting excessive sebum secretion
DE2942021A1 (de) * 1979-10-17 1981-04-30 Bristol Myers Co Dermatologisches mittel
FR2490631A1 (fr) * 1980-09-24 1982-03-26 Roussel Uclaf Nouvelle composition lipidique utilisable en dietetique, reanimation et therapeutique
US5145686A (en) * 1982-02-03 1992-09-08 Efamol Limited Topical pharmaceutical compositions
ATE24266T1 (de) * 1982-04-16 1987-01-15 Nestle Sa Lipidhaltige zusammensetzung fuer die orale, enterale oder parenterale ernaehrung.
US5011855A (en) * 1982-04-16 1991-04-30 Nestec S.A. Cosmetic and dermatological compositions containing γ-linolenic acid
ATE22533T1 (de) * 1982-04-29 1986-10-15 Efamol Ltd Pharmazeutische zusammensetzung.
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition
FR2569347B1 (fr) * 1984-08-22 1987-10-23 Mollet Marc Composition lipidique favorisant la pousse des phaneres et produits cosmetiques en renfermant
GB8516906D0 (en) * 1985-07-04 1985-08-07 Efamol Ltd Pharmaceutical & dietary composition
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
FR2588187B1 (fr) * 1985-10-07 1989-04-14 Rochas Parfums Nouvelles compositions cosmetiques ou dermatologiques riches en acides gras essentiels presents a la fois sous forme de triglycerides et sous forme libre ou salifiee
JPS6284041A (ja) * 1985-10-08 1987-04-17 Nitto Electric Ind Co Ltd γ−リノレン酸含有包接物
JPS62187425A (ja) * 1985-10-14 1987-08-15 Michio Nakanishi リノレン酸系化合物含有組成物
SE8604117D0 (sv) * 1986-09-29 1986-09-29 Kabivitrum Ab Composition
JPH0832628B2 (ja) * 1986-12-17 1996-03-29 株式会社ミドリ十字 トリグリセリド組成物
JPS6451496A (en) * 1987-08-21 1989-02-27 Nippon Oils & Fats Co Ltd Method of refining oil containing gamma-linolenic acid
FR2623692B1 (fr) * 1987-11-30 1991-05-03 Vernin Jean Gilles Nouvelle huile dietetique
GB8729153D0 (en) * 1987-12-14 1988-01-27 Efamol Ltd Fatty acid compositions
IE63225B1 (en) * 1988-09-13 1995-04-05 Efamol Holdings Use of fatty acids in the treatment of myalgic encephalomyelitis
GB9001121D0 (en) * 1990-01-18 1990-03-21 Efamol Holdings Efa compositions and therapy

Also Published As

Publication number Publication date
JPH05201924A (ja) 1993-08-10
SG49739A1 (en) 1998-06-15
US5614208A (en) 1997-03-25
US5328691A (en) 1994-07-12
KR930000664A (ko) 1993-01-15
CA2069600A1 (en) 1992-12-04
ES2085567T3 (es) 1996-06-01
FI103867B (fi) 1999-10-15
KR100274727B1 (ko) 2000-12-15
NO180804B (no) 1997-03-24
NO180804C (no) 1997-07-02
AU652827B2 (en) 1994-09-08
KR100277424B1 (ko) 2000-12-15
TW288975B (de) 1996-10-21
IE921663A1 (en) 1992-12-16
FI922542A0 (fi) 1992-06-02
FI922542L (fi) 1992-12-04
NO922183D0 (no) 1992-06-02
US5552150A (en) 1996-09-03
JP2704922B2 (ja) 1998-01-26
GR3019840T3 (en) 1996-08-31
ZA923913B (en) 1993-02-24
DE69209571T2 (de) 1996-09-05
NZ242898A (en) 1994-12-22
DK0520624T3 (da) 1996-05-06
FI103867B1 (fi) 1999-10-15
GB9111900D0 (en) 1991-07-24
AU1727892A (en) 1992-12-10
US5620701A (en) 1997-04-15
NO922183L (no) 1992-12-04
ATE136214T1 (de) 1996-04-15
EP0520624B1 (de) 1996-04-03
EP0520624A1 (de) 1992-12-30
IE75224B1 (en) 1997-08-27
CA2069600C (en) 2004-05-04
DE69209571D1 (de) 1996-05-09

Similar Documents

Publication Publication Date Title
EP0520624B1 (de) Nahrungs-, pharmazeutische und kosmetische Zubereitung, Dilinoleoyl-mono-gamma-linolenyl-glycerol enthaltend
US5670540A (en) Triglycerides of fatty acids
JP2003319759A (ja) 異性体濃縮共役リノール酸組成物の使用方法
CA2196880C (en) Nervonic acid compositions
EP0437520B1 (de) Triglyceride und nahrungszusammensetzung die diese enthält
WO2015050220A1 (ja) 油脂組成物
AU711302C (en) Nervonic acid compositions
CN106232113B (zh) 不饱和脂肪酸的吸收促进剂

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)